Rilpivirine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Rilpivirine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can affect your heart's rhythm. Buprenorphine (for pain or opioid treatment) and rilpivirine (an HIV medicine) can each stretch out a part of your heartbeat called the QT interval. When you take them together, that effect can add up, which in rare cases could lead to a dangerous irregular heartbeat.
This concern is based on how the drugs work rather than lots of real-world reports, so try not to worry. Your care team can manage this safely, sometimes by choosing a different HIV medicine or by keeping a closer eye on your heart. Please don't stop either medicine on your own. Just talk with your doctor or pharmacist about the best plan for you.
Mechanism: additive QT interval prolongation from concomitant buprenorphine and rilpivirine, both of which carry QT-prolonging potential. This is a pharmacodynamic (PD) interaction, not PK; neither agent is a prodrug affecting the other's activation.
- Direction/effect: increased risk of QTc prolongation and torsade de pointes.
- Evidence: theoretical; magnitude not quantified.
- Onset: unspecified.
- Management: per labeling, consider an alternative to rilpivirine when combined with a drug carrying known torsade risk. If used together, assess baseline and follow-up ECG, correct electrolytes (K+, Mg2+), and review other QT-prolonging agents and risk factors (bradycardia, structural heart disease).
What happens
An increased risk of QT interval prolongation and torsade de pointes
Interaction Deep Dive
Taking rilpivirine together with an agent that prolongs the QT interval can raise the likelihood of QT interval prolongation and torsade de pointes. When rilpivirine is given alongside a medication carrying a known risk of torsade de pointes, alternatives to rilpivirine should be considered12.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Keep taking both medicines as prescribed unless your care team tells you otherwise. Because this involves your heart rhythm, your team has a few good options:
- They may consider a different HIV medicine in place of rilpivirine, since the label suggests this when it is paired with a drug that can affect QT.
- They may monitor you more closely, which can include an ECG and checking your blood minerals like potassium and magnesium.
- They will review your other medicines for any that also affect heart rhythm.
Tell your pharmacist or prescriber if you feel fainting, dizziness, a racing or irregular heartbeat, or palpitations.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Rilpivirine and Buprenorphine together?
Combining buprenorphine and rilpivirine can add up to a higher risk of QT-related heart rhythm problems, so ask your care team whether a different HIV medicine or extra heart monitoring is right for you. Do not stop either drug on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Rilpivirine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Rilpivirine and Buprenorphine interaction managed?
Keep taking both medicines as prescribed unless your care team tells you otherwise. Because this involves your heart rhythm, your team has a few good options: They may consider a different HIV medicine in place of rilpivirine, since the label suggests this when it is paired with a drug that can affect QT. They may monitor you more closely, which can include an ECG and checking your blood minerals… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Rilpivirine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
Keep reading about Buprenorphine
Keep reading about Rilpivirine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist